A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) — GLIDER

Primary Sjögren Syndrome Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered GLPG3970 for 12 Weeks in Adult Subjects With Active Primary Sjögren's Syndrome

Status Terminated

Clinical Trial Summary

This is a first exploration of GLPG3970 in participants with active primary Sjogren's Syndrome (pSS) to evaluate the efficacy, safety and tolerability and to determine its pharmacokinetics (PK) profile compared to placebo.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04700280
Study type	Interventional
Source	Galapagos NV
Contact
Status	Terminated
Phase	Phase 2
Start date	January 28, 2021
Completion date	December 27, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06440525` - A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome	Phase 2
Not yet recruiting	`NCT03140111` - LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients	N/A
Not yet recruiting	`NCT06049368` - 68Ga-P16-093 PET/CT Imaging in the Salivary Gland	Phase 1/Phase 2
Not yet recruiting	`NCT03614299` - Eye Dryness Evaluation in Primary Sjögren's Syndrome
Not yet recruiting	`NCT03126383` - Inflammatory Myopathies in Primary Sjögren's Syndrome	N/A
Recruiting	`NCT04830644` - A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.	Phase 2
Not yet recruiting	`NCT03765593` - Biomarkers in Primary Sjögren's Syndrome
Completed	`NCT01081184` - Neurotrophins Implications in Primary Sjögren Syndrome	N/A
Completed	`NCT05670535` - Sjögren and Gynecologic Considerations
Completed	`NCT03226444` - Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome	Phase 1/Phase 2
Completed	`NCT04816370` - Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions	N/A
Completed	`NCT05380804` - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Completed	`NCT03130062` - Resistance Exercise in Woman With Primary Sjörgen Syndrome.	N/A
Completed	`NCT04093531` - Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome	Phase 1
Recruiting	`NCT03509064` - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed	`NCT04224454` - Vaccine Coverage and Primary Sjögren'Syndrome
Completed	`NCT04960605` - Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome	N/A
Recruiting	`NCT06361745` - Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases	N/A